Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Silvia Mancuso
Observed name:
S. Mancuso
Institution:
Sapienza University of Rome
Observed institutions:
Policlinico Umberto I,
Sapienza University of Rome
ORCID:
0000-0002-5820-3316
Observed ORCID:
0000-0002-5820-3316
OpenAlex ID:
A5047003582
Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome
2022
·
Simona Truglia
, Antonella Capozzi
, et al.
·
Frontiers in Immunology
·
42
Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome
2019
·
Valeria Manganelli
, Simona Truglia
, et al.
·
Frontiers in Immunology
·
39
PDF
‘Non-criteria antiphospholipid antibodies’: bridging the gap between seropositive and seronegative antiphospholipid syndrome
2021
·
Simona Truglia
, Silvia Mancuso
, et al.
·
Rheumatology
·
37
Does seronegative obstetric APS exist? “pro” and “cons”
2019
·
Fabrizio Conti
, Laura Andreoli
, et al.
·
Autoimmunity Reviews
·
35
A Monocentric Cohort of Obstetric Seronegative Anti-Phospholipid Syndrome
2018
·
Simona Truglia
, Antonella Capozzi
, et al.
·
Frontiers in Immunology
·
31
PDF
Antiphospholipid Syndrome: Insights into Molecular Mechanisms and Clinical Manifestations
2024
·
Alessandra Ida Celia
, Mattia Galli
, et al.
·
Journal of Clinical Medicine
·
21
PDF
Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience
2021
·
Francesca Romana Spinelli
, Fulvia Ceccarelli
, et al.
·
Clinical and Experimental Rheumatology
·
20
Antibody profiles in the mosaic of ‘seronegative’ APS syndrome
2024
·
Simona Truglia
, Gloria Riitano
, et al.
·
Clinical & Experimental Immunology
·
19
PDF
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
2023
·
Francesca Romana Spinelli
, Cristina Garufi
, et al.
·
Scientific Reports
·
17
PDF
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational study
2022
·
Rossana Scrivo
, Chiara Castellani
, et al.
·
Clinical and Experimental Rheumatology
·
17
Comprehensive disease control in systemic lupus erythematosus
2021
·
Fulvia Ceccarelli
, Giulio Olivieri
, et al.
·
Seminars in Arthritis and Rheumatism
·
14
Carbamylation of β2-glycoprotein I generates new autoantigens for antiphospholipid syndrome: a new tool for diagnosis of ‘seronegative’ patients
2022
·
Antonella Capozzi
, Simona Truglia
, et al.
·
Rheumatology
·
13
Updated systematic literature review and meta-analysis to inform the Italian Society of Rheumatology Recommendations on the treatment of rheumatoid arthritis-associated interstitial lung disease
2025
·
A. Fassio
, M. Sebastiani
, et al.
·
Autoimmunity Reviews
·
12
Janus kinases inhibitors for treating patients with rhupus
2020
·
Cristina Garufi
, Silvia Mancuso
, et al.
·
Joint Bone Spine
·
12
Anti-vimentin/cardiolipin IgA in the anti-phospholipid syndrome: A new tool for ‘seronegative’ diagnosis
2021
·
Antonella Capozzi
, Gloria Riitano
, et al.
·
Clinical & Experimental Immunology
·
11
PDF
Anti-β2glycoprotein I-induced neutrophil extracellular traps cause endothelial activation
2025
·
Silvia Mancuso
, Mattia Caliste
, et al.
·
Rheumatology
·
10
PDF
Fibromyalgia, mood disorders and chronic damage are the main determinants of worse quality of life in systemic lupus erythematosus patients: Results from a cross-sectional analysis
2024
·
Fulvia Ceccarelli
, Claudia Ciancarella
, et al.
·
Lupus
·
10
Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab: a case report
2020
·
Fulvia Ceccarelli
, Silvia Mancuso
, et al.
·
Rheumatology
·
10
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors: results from a monocentric cohort
2021
·
Fulvia Ceccarelli
, Francesca Romana Spinelli
, et al.
·
Clinical and Experimental Rheumatology
·
9
Should we vaccinate during an active rheumatic disease?
2023
·
Marc Bijl
, Johanna Westra
, et al.
·
Autoimmunity Reviews
·
8
PDF
Rapid response to anifrolumab in lupus related joint involvement as assessed by ultrasonography: A case series study
2024
·
Fulvia Ceccarelli
, Claudia Ciancarella
, et al.
·
Joint Bone Spine
·
7
Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus
2021
·
Silvia Mancuso
, Francesca Romana Spinelli
, et al.
·
Clinical and Experimental Rheumatology
·
7
PDF
COVID-19 and systemic sclerosis: analysis of lifestyle changes during the SARS-CoV-2 pandemic in an Italian single-center cohort
2020
·
Greta Pellegrino
, Davide Mohammad Reza Beigi
, et al.
·
Clinical Rheumatology
·
7
PDF
Antigenic assessment for the β2-glycoprotein I/Platelet factor 4 complex in thrombotic patients with antiphospholipid syndrome
2026
·
Francesca Villani
, Antonella Capozzi
, et al.
·
Frontiers in Immunology
·
6
PDF
The Italian Society for Rheumatology guidelines for the treatment of patients with rheumatoid arthritis and interstitial lung disease
2025
·
Chiara Crotti
, Nicola Ughi
, et al.
·
Reumatismo
·
6
Show more works
View as search
Works count:
67
Citation count:
446
H-index:
12
I10-index:
18
Year
Topic
Type